This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Ashish Garg, Ph.D.
Director, Drug Product Development at Eli Lilly and Company
Speaker

Profile

Ashish Garg is currently Director of Engineering at Eli Lilly and Company. He earned his Bachelors & Master of Technology from Indian Institute of Technology, and his PhD in from the University of Minnesota. His professional journey began at TEVA Pharmaceuticals, where he developed complex injectable formulations based on liposomes and polymeric microspheres. In 2015, Ashish joined Eli Lilly and Company. His work here has been centered on the development and commercialization of peptides, insulin, and oligonucleotide-based parenteral products. His contributions have led to multiple patents and publications in the field of drug development. Ashish’s motivation is rooted in his desire to directly impact patients’ lives. His multidisciplinary approach, bridging science and engineering, has proven beneficial for both the industry and those in need of medical solutions.

Agenda Sessions

  • Designing a Safe, Sustainable, and Efficient Drug Manufacturing Processes for Oligonucleotide Based Products

    09:05
  • Process Development & Manufacturing of Oligos

    11:15